Cargando…

Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy

PURPOSE: This study aims to compare the accuracy of mean GH profile (GHP) < 2.5 ng/ml and single fasting GH (SGH) < 1 ng/ml in the evaluation of disease control in acromegaly patients during somatostatin receptor ligands (SRLs) therapy. METHODS: We retrospectively enrolled 100 acromegaly patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bona, C., Prencipe, N., Berton, A. M., Bioletto, F., Parasiliti-Caprino, M., Gasco, V., Ghigo, E., Grottoli, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463242/ https://www.ncbi.nlm.nih.gov/pubmed/35748978 http://dx.doi.org/10.1007/s40618-022-01830-6

Ejemplares similares

Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests
por: Bioletto, Fabio, et al.
Publicado: (2021)

Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment
por: Prencipe, N., et al.
Publicado: (2020)

GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency?
por: Gasco, V., et al.
Publicado: (2023)

MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis
por: Bioletto, Fabio, et al.
Publicado: (2022)

Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone
por: Bioletto, F., et al.
Publicado: (2022)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study
por: Berton, Alessandro Maria, et al.
Publicado: (2023)

Effects of combination therapy: somatostatin analogues and dopamine agonists on GH and IGF1 levels in acromegaly
por: VALEA, ANA, et al.
Publicado: (2015)

THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
por: Costanza, Flavia, et al.
Publicado: (2023)

Difficulties in diagnosing acromegaly, acromegaly with apparently normal GH: Micromegaly
por: Demir, Ahmet Numan, et al.
Publicado: (2023)

Atypical Course of a Patient With AIP-Positive Acromegaly: From GH Excess to GH Deficiency and Back to GH Excess
por: García-de-la-Torre, Keren-Sandyn, et al.
Publicado: (2023)

Association of Urine Metanephrine Levels with CardiometaBolic Risk: An Observational Retrospective Study
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Isolated anterior pituitary dysfunction in adulthood
por: Prencipe, Nunzia, et al.
Publicado: (2023)

Neuroendocrine response to diclofenac in healthy subjects: a pilot study
por: Varaldo, E., et al.
Publicado: (2023)

Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
por: Bioletto, Fabio, et al.
Publicado: (2022)

The Future of Somatostatin Receptor Ligands in Acromegaly
por: Gadelha, Monica R, et al.
Publicado: (2021)

Somatostatin, as a Bridge Between the GH-Axis and the Gth-Axis
por: Mizrahi, Naama, et al.
Publicado: (2021)

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment
por: Gasco, Valentina, et al.
Publicado: (2021)

Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly
por: Martín-Rodríguez, Juan Francisco, et al.
Publicado: (2013)

First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence
por: Cambria, V., et al.
Publicado: (2021)

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas
por: Araujo-Castro, Marta, et al.
Publicado: (2020)

Novel Somatostatin Receptor Ligands Therapies for Acromegaly
por: Paragliola, Rosa Maria, et al.
Publicado: (2018)

Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience
por: Dutta, Pinaki, et al.
Publicado: (2015)

GH Secretory Dynamics and Responsiveness to SMS 201-995 Treatment in Acromegaly
por: Kim, Sung Woon, et al.
Publicado: (1988)

Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects
por: Bollati, Martina, et al.
Publicado: (2022)

GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly
por: Wu, Xia, et al.
Publicado: (2018)

Surgical Remission of Acromegaly Resolves Neuroglycopenia and Paradoxical Rise in GH after OGTT
por: Magar, Maria, et al.
Publicado: (2021)

GH Receptor Exon 3 Genotype and Echocardiographic Abnormalities in Patients With Active Acromegaly
por: Serrano, Karla, et al.
Publicado: (2021)

THU483 Role Of Excess GH On Breast Cancer Aggressiveness And Metastasis In Acromegaly
por: Hun, Ju, et al.
Publicado: (2023)

Regulation of GH and GH Signaling by Nutrients
por: Caputo, Marina, et al.
Publicado: (2021)

Is GH Replacement for Adult GH Deficiency Safe?
por: Melmed, Shlomo
Publicado: (2022)

GH deficiency status combined with GH receptor polymorphism affects response to GH in children
por: Valsesia, Armand, et al.
Publicado: (2015)

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant
por: Strasburger, Christian J, et al.
Publicado: (2018)

Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Cardinal, Tyler, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly
por: Gil, Joan, et al.
Publicado: (2021)

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
por: Berton, A. M., et al.
Publicado: (2020)

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
por: Saksis, Rihards, et al.
Publicado: (2023)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency
por: Bright, George, et al.
Publicado: (2021)

Immobilization of Glycoside Hydrolase Families GH1, GH13, and GH70: State of the Art and Perspectives
por: Graebin, Natália G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s16mmnoqij60rf4p6vpprms338